http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60237069-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4811e7eae15e0f1e32cc6a222ce30
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-00
filingDate 1984-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57c6bb844f833b95211043972b22dc53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90114f45dbdcbfdbcc767b2e6cb5ccab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14589f0f3090303a942a78e7f2ae1a3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc6ae967e13a6d3e894763c4ee685a01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2eaff57a6434cc8fc9c3a325af5d9cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6fb62f75f77f3c51f1ef076ada2c64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bbb04d34f643aaf07c48e705a71c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a0946034547dd8a48e48094bf47e89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_498b220b1afc2b012b5f985d9f860511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c558fa122314552554c685c1fe6538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac080e8daf3f854354f369e658406aba
publicationDate 1985-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S60237069-A
titleOfInvention 1,4-dihydro-4-oxoquinoline derivative and its salt
abstract NEW MATERIAL:The compound of formula I [R 1 is H or carboxyl-protecting group; R 2 is (substituted) aryl; R 3 is halogen or (substituted) cyclic amino] and its salt. n EXAMPLE: 7-Chloro-6-fluoro-1,4-dihydro-1-( 4-methoxyphenyl )-4-oxo-3-quinolinecarboxylic acid. n USE: An antibacterial agent exhibiting strong antibacterial activity against Gram- positive and Gram-negative bacteria, especially to the bacteria resistant to antibiotic substances, keeping high concentration in blood by oral or parenteral administration, and having high safety. n PREPARATION: The compound of formula I or its salt can be prepared by cyclizing the compound of formula II (R 3a is halogen) or its salt in the presence or absence of a base, and if necessary, reacting the product with the compound of formula R 3b -H [R 3b is (substituted) cyclic amino]. n COPYRIGHT: (C)1985,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9505373-A1
priorityDate 1984-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234846754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410270834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13500616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69141

Total number of triples: 34.